Leading Global Pharmaceutical Company in India
Toonaangevend mondiaal farmaceutisch bedrijf in India | Anti-retrovirale medicijnen
Hetero is het eerste bedrijf in India dat de generieke versie van de remdesivir-injectie, COVIFOR, in India lanceert, die wordt gebruikt voor de behandeling van ziekenhuisopnames van COVID-19. Klik hier voor meer informatie.
- Type
- distributor (our classification of the record, not a statement by the company)
- Role
- Distributor
- Location
- Netherlands
- Website
- https://hetero.com
- Categories
- Farmaceutische productie
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- domain-registered (green), checked 2026-08-08 Domain registry record
- debarment-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- sanctions-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)